← All Investors
CRISPR THERAPEUTICS AG
CRSP
Holders
6
Combined Value
$627M
Combined Shares
13,193,132
Current Price
$53.09
52W High
$78.48
vs 52W High
−32.4%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Cathie Wood - ARK Invest | $538M | 4.19% | ~$49.59 | +7.1% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $64M | 0.01% | ~$54.40 | −2.4% | Sold Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $17M | 0.01% | ~$46.96 | +13.1% | Bought Q1 2026 | Q1 2026 |
| Paul Tudor Jones - Tudor Investment | $4.2M | 0.01% | ~$39.32 | +35.0% | Sold Q1 2026 | Q1 2026 |
| Steve Cohen - Point72 | $2.1M | 0.00% | ~$52.44 | +1.2% | Sold Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $1.1M | 0.00% | ~$41.79 | +27.1% | Bought Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 6 | 13,193,132 | +6.9% | $627M | $47.57 |
| Q4 2025 | 6 | 12,337,648 | +3.7% | $646M | $52.44 |
| Q3 2025 | 5 | 11,899,228 | +2.1% | $771M | $64.81 |
| Q2 2025 | 6 | 11,658,576 | −3.5% | $567M | $48.64 |
| Q1 2025 | 6 | 12,082,728 | +10.1% | $411M | $34.03 |
| Q4 2024 | 4 | 10,970,195 | +19.5% | $431M | $39.36 |
| Q3 2024 | 4 | 9,182,656 | +1.7% | $431M | $46.98 |
| Q2 2024 | 3 | 9,029,224 | — | $487M | $54.01 |